Attachment I_NSDUH Incentives Exp Power Analysis_Final_9-12-22

Attachment I_NSDUH Incentives Exp Power Analysis_Final_9-12-22.pdf

2022 National Survey on Drug Use and Health (NSDUH)

Attachment I_NSDUH Incentives Exp Power Analysis_Final_9-12-22

OMB: 0930-0110

Document [pdf]
Download: pdf | pdf
Power Analysis Details for NSDUH Incentives Experiment
Key Assumptions Applied to the SRR and IRR Power Calculations
1) The power analysis assumed a difference of at least 5% in SRRs or IRRs between test and
control incentive conditions would be statistically and practically meaningful for inferring a
positive improvement in response rates from the increased incentive amounts.
2) The power analysis was conducted using two alpha (significance) levels for marginal mean
differences:
• α = 0.05
• α = 0.10
Note that the SDUs presented in Table 2.3 and the selected interview respondents presented
in Table 2.4 are based on the calculations assuming α = 0.05. Focusing on α = 0.05 was
intended to ensure a sufficient number of Quarter 4 2022 SDUs and selected interview
respondents will be selected for each of the three test incentive conditions. This approach
also conforms with the conventional significance level used for statistical inference.
Table 2.3

Sample Dwelling Units for the Four Experimental Conditions for the
Incentives Experiment

$30 Interview Incentive
$50 Interview Incentive
Screener Incentive Marginal
Totals

Table 2.4

$0 Screener
Incentive
remainder
6,250

>12,500

$5 Screener
Incentive
6,250
6,250

Interview Incentive
Marginal Totals
>12,500
12,500

12,500

Selected Interview Respondents for the Four Experimental Conditions for the
Incentives Experiment

No Screening Incentive
$5 Screening Incentive
Interview Incentive
Marginal Totals

$30
Interview
Incentive
Remainder
of sample
2,100
>4,200

$50
Interview
Incentive
2,100
2,100
4,200

Screening
Incentive Marginal
Totals
>4,200
4,200

3) One-sided tests were assumed, which are directional. The effect in the desired direction was
used. That is, the null hypothesis of no effect from increased incentives is rejected if the
response rates with higher incentives are at least five percentage points larger than response
rates under current incentive levels.
4) The statistical power assumed was 0.80.
5) The degrees of freedom were assumed to be 60. The degrees of freedom correspond to the
number of variance strata, which should be larger than 60. However, anything over 60 has
very little impact on the results, so 60 is often used for simplicity.
6) The design effects (DEFFs) applied to the power calculations accounted for clustering of the
treatment cases and unequal weighting effect at the DU level (i.e., because DUs are selected
within segments) under the current state-based design. The DEFFs for SRR sample size
calculations were 4.69 with α = 0.05 and 4.18 with α = 0.10. The DEFFs for IRR sample size
calculations were 3.04 with α = 0.05 and 3.01 with α = 0.10. Note that the larger alpha
requires a smaller sample size in each treatment group. In turn, this means less clustering of
treatment cases and a smaller design effect.
7) The DU eligibility was assumed to be 85%, the control screener rate was assumed to be 27%,
and the persons selected per DU was assumed to be 68.6%.
8) For calculations, the treatment and control groups for each test were expected to have the
same number of SDUs. Because the experiment involves four treatment conditions in a 2x2
experiment (Table 2.2), the experiment requiring the larger sample sizes would determine the
sample sizes for both tests. The incentives experiment is embedded into production data
collection, so the number of SDUs in Q4 of 2022 will far exceed the number needed for both
experiments. All excess SDUs will be assigned to the current control condition.
As shown in the second table below, the power analysis calculations indicated a total of 11,436
SDUs (22,871 ÷ 2) will need to be assigned to each interview incentive condition. This exceeds
the number needed for the screener experiment, so the same number is then assigned to the
screener incentive conditions, too. That is, each marginal total is 11,436. Taking into
consideration the potential for one or more key assumptions to prove incorrect and other
unforeseen circumstances, RTI recommended the higher number of 12,500 SDUs to ensure
sufficient sample sizes for the incentives experiment. This number of SDUs is presented in the
marginal total SDUs presented in Table 2.3. The marginal total SDUs were also used to derive
the selected interview respondents needed in Table 2.4.

Table A.1: Assumptions and Calculations for the SRR Sample Sizes
Alpha:

0.05

0.10

Probabilities:
Null Hypothesis - No Treatment Effect
Alternative hypothesis for treatment group
Difference (minimum detectable effect)
Combined (for null hypothesis variance)

0.270
0.320
0.050
0.295

0.270
0.320
0.050
0.295

Sampling Allocation:
Null hypothesis proportion
Alternative hypothesis proportion

0.500
0.500

0.500
0.500

0.8316
0.8290

0.8312
0.8287

5%
1
80%
60
1.671
0.848

10%
1
80%
60
1.296
0.848

Design Effect (DEFF):
DU DEFF

4.69

4.18

Assumed DU Eligibility Rate (from 2019):

0.85

0.85

2,074
9,729

1,526
6,380

11,384

7,466

Variance Calculation:
Null hypothesis variance
Alternative hypothesis variance
Test Information:
Alpha
# of sides in test
Power
Degrees of freedom
t-alpha
t-beta

Sample Size (n) Calculations:
Effective n required (eligible DUs for attempted
screening)
Actual n required (accounts for DEFF)
Initial n required (accounts for eligibility,
conservatively)

Notes:
1. Formula for sample size calculation for two proportions (using normal approximation) based on Fleiss (1981),
but modified to use the t-distribution rather than the standard normal z-distribution.
2. SRR and IRR null hypothesis values and associated design effects were obtained from Q4 2021 NSDUH.
3. Eligibility rate was obtained from the 2019 NSDUH, to be more conservative than current mixed sample
assumptions.

Table A.2: Assumptions and Calculations for the IRR Sample Sizes
Alpha:

0.05

0.10

Probabilities:
Null Hypothesis - No Treatment Effect
Alternative hypothesis for treatment group
Difference (minimum detectable effect)
Combined (for null hypothesis variance)

0.456
0.506
0.050
0.481

0.456
0.506
0.050
0.481

Sampling Allocation:
Null hypothesis proportion
Alternative hypothesis proportion

0.500
0.500

0.500
0.500

0.9986
0.9961

0.9986
0.9961

5%
1
80%
60
1.671
0.848

10%
1
80%
60
1.296
0.848

Design Effect (DEFF):
Person DEFF

3.04

3.01

Person Eligibility Rate:

1.0

1.0

Sample Size (n) Calculations:
Effective n required (total selected persons)
Actual n required (accounts for DEFF)
Initial n required (accounts for person eligibility)

2,531
7,684
7,684

1,834
5,519
5,519

Expected persons selected per screened DU

0.686

0.686

Screened DUs required
Assumed Screener Rate

5,269
0.270

3,784
0.270

Eligible DUs required
DU Eligibility Rate

19,546
0.85

14,037
0.85

Initial sample DUs required

22,871

16,425

Variance Calculation:
Null hypothesis variance
Alternative hypothesis variance
Test Information:
Alpha
# of sides in test
Power
Degrees of freedom
t-alpha
t-beta

Notes:

1. Formula for sample size calculation for two proportions (using normal approximation) based on Fleiss (1981),
but modified to use the t-distribution rather than the standard normal z-distribution.
2. SRR and IRR null hypothesis values and associated design effects were obtained from Q4 2021 NSDUH.
3. Eligibility rate was obtained from the 2019 NSDUH, to be more conservative than current mixed sample
assumptions.


File Typeapplication/pdf
File TitleMicrosoft Word - Attachment I_NSDUH Incentives Exp Power Analysis_Final_9-12-22
Authorcjewett
File Modified2022-09-14
File Created2022-09-14

© 2024 OMB.report | Privacy Policy